Magnesium sulphate is indicated in the management of pre-eclampsia and also for fetal neuroprotection if there is a risk of preterm delivery. Intravenous magnesium has been repeatedly associated with medication errors internationally and locally. One US report described 52 cases of accidental IV magnesium overdose. IV magnesium errors may result in serious patient harm or death. Such errors are well understood and effective preventative strategies are available.

Please click on the link below to see the alert:

Safety Alert: IV Magnesium Sulphate in Obstetrics